TrialHuman vaccines2011

Comparison of the immunogenicity of the human papillomavirus (HPV)-16/18 vaccine and the HPV-6/11/16/18 vaccine for oncogenic non-vaccine types HPV-31 and HPV-45 in healthy women aged 18-45 years.

Mark H Einstein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.